<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="editorial" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Protein Cell</journal-id>
<journal-id journal-id-type="iso-abbrev">Protein Cell</journal-id>
<journal-title-group>
<journal-title>Protein &amp; Cell</journal-title>
</journal-title-group>
<issn pub-type="ppub">1674-800X</issn>
<issn pub-type="epub">1674-8018</issn>
<publisher>
<publisher-name>Higher Education Press</publisher-name>
<publisher-loc>Beijing</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32172500</article-id>
<article-id pub-id-type="pmc">7251010</article-id>
<article-id pub-id-type="publisher-id">697</article-id>
<article-id pub-id-type="doi">10.1007/s13238-020-00697-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Commentary</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Seven facts and five initiatives for gut microbiome research</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Danyi</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Chunhui</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Faming</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Ruifu</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lan</surname>
<given-names>Canhui</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ma</surname>
<given-names>Yonghui</given-names>
</name>
<address>
<email>yhma@xmu.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Jun</given-names>
</name>
<address>
<email>junwang@im.ac.cn</email>
</address>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.418873.1</institution-id><institution>Beijing Rexinchang Biotechnology Research Institute Co. Ltd, </institution></institution-wrap>Beijing, 100011 China </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.452511.6</institution-id><institution>Medical Center for Digestive Diseases, </institution><institution>The Second Affiliated Hospital of Nanjing Medical University, </institution></institution-wrap>Nanjing, 210011 China </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution>Key Lab of Holistic Integrative Enterology, </institution><institution>Nanjing Medical University, </institution></institution-wrap>Nanjing, 210011 China </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution>Division of Microbiotherapy, </institution><institution>Sir Run Run Shaw Hospital, Nanjing Medical University, </institution></institution-wrap>Nanjing, 211166 China </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.198530.6</institution-id><institution-id institution-id-type="ISNI">0000 0000 8803 2373</institution-id><institution>State Key Laboratory of Pathogen and Biosecurity, </institution><institution>Beijing Institute of Microbiology and Epidemiology, </institution></institution-wrap>Beijing, 100071 China </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.12955.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2264 7233</institution-id><institution>Centre for Bioethics, Medical College, </institution><institution>Xiamen University, </institution></institution-wrap>Xiamen, 361102 China </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.9227.e</institution-id><institution-id institution-id-type="ISNI">0000000119573309</institution-id><institution>CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, </institution><institution>Chinese Academy of Science, </institution></institution-wrap>Beijing, 100101 China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>14</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>14</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2020</year>
</pub-date>
<volume>11</volume>
<issue>6</issue>
<fpage>391</fpage>
<lpage>400</lpage>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p id="Par1">The gut microbiome has attracted increasing attention over the past 15 years. Along with the fast-growing body of research literature and media reports, the public’s opinions on the gut microbiome have begun to appear polarized.</p>
<p id="Par2">Some believe that the gut microbiome is at the core of human health and is related to every single disease. To the opposite, some people question the scientific basis of gut microbiome studies and criticize that many of them are farfetched; there is even a joke spreading in the biomedical research field—“keeping gut microbiome in mind, no mechanism is hard to find”.</p>
<p id="Par3">However, neither view is impartial. Here, we present seven facts about the gut microbiome research, and provide five initiatives to promote the healthy development of this field.</p>
<sec id="Sec1">
<title>FACT 1. THE GUT MICROBIOME IS THE LEADING EDGE OF SCIENTIFIC RESEARCH</title>
<p id="Par4">There are more than 50,000 gut microbiome research articles in the database of Web of Science since 2000. Prior to 2005, the relevant publications averaged no more than 500 per year. However, as of December 18, 2019, there are already more than 9,500 publications year-to-date, which has grown about 30 times since 2000, 6 times since 2010, and doubled since 2015 (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).<fig id="Fig1"><label>Figure 1</label><caption><p><bold>Growth of gut microbiome studies in Web of Science database</bold>. Query “TS = (gut OR intestine OR bowel OR intestinal OR colon OR colorectal OR gastrointestine OR gastrointestinal) AND TS = (microbiome OR microbiota OR flora OR microbe OR microbes OR commensal OR symbiont OR pathobiont OR mycobiome OR virome OR metagenome OR meta-genome)” and then retrieve those published from 2000–2019. Database accessed on Dec. 18, 2019</p></caption><graphic id="MO1" xlink:href="13238_2020_697_Fig1_HTML"></graphic></fig></p>
<p id="Par5">Among these publications, more than 2,000 are highly cited (the top one percent in each of the 22 ESI subject areas per year), published in 449 journals. The top 15 journals with the most highly cited articles are <italic>Nature</italic>, <italic>Gut</italic>, <italic>Science</italic>, <italic>PNAS</italic>, <italic>Cell Host</italic> &amp; <italic>Microbe</italic>, <italic>Gastroenterology</italic>, <italic>Cell</italic>, <italic>PloS One</italic>, <italic>ISME Journal</italic>, <italic>Nature Communications</italic>, <italic>Nature Reviews Microbiology</italic>, <italic>Nature Reviews Gastroenterology</italic> &amp; <italic>Hepatology</italic>, <italic>Nutrients</italic>, <italic>Immunity</italic>, and <italic>Nature Medicine</italic>.</p>
<p id="Par6">More than 170 countries and regions around the world contributed to these highly cited studies, with universal participation by major countries including the USA, China, United Kingdom, Germany, France, Canada, Italy, Japan, Spain, Netherlands, Australia, etc. Among them, China’s contribution (including Hong Kong, Macao and Taiwan) has made considerable progress in the past decade (Fig. <xref ref-type="fig" rid="Fig2">2</xref>).<fig id="Fig2"><label>Figure 2</label><caption><p><bold>Proportion of country contributions</bold></p></caption><graphic id="MO2" xlink:href="13238_2020_697_Fig2_HTML"></graphic></fig></p>
<p id="Par7">Behind the rise of gut microbiome research is the rapid development of cutting-edge biological research technologies (Gilbert et al., <xref ref-type="bibr" rid="CR31">2016</xref>; Gilbert et al., <xref ref-type="bibr" rid="CR32">2018</xref>), including germ-free animal models (Uzbay, <xref ref-type="bibr" rid="CR108">2019</xref>), next-generation sequencing technologies (Shendure et al., <xref ref-type="bibr" rid="CR93">2017</xref>), and multi-omics approaches (Quince et al., <xref ref-type="bibr" rid="CR74">2017</xref>; Lagier et al., <xref ref-type="bibr" rid="CR52">2018</xref>; Zhang et al., <xref ref-type="bibr" rid="CR120">2019</xref>) such as metagenomics, metatranscriptomics, metabolomics, and culturomics. The development and application of these technologies not only enable researchers to analyze composition and structure of gut microbiome, but also make it possible to study and verify the function of the microbiome and its association with health and disease from different interdisciplinary perspectives.</p>
</sec>
<sec id="Sec2">
<title>FACT 2. BASIC AND TRANSLATIONAL RESEARCH OF THE GUT MICROBIOME IS EXPANDING GLOBALLY</title>
<p id="Par8">The rapid development of the gut microbiome research in recent years is not only related to the scientific community’s deepening understanding of the function of the microbiome, but also inseparable from each nation’s strategic support.</p>
<p id="Par9">Of these, the Human Microbiome Project (HMP) supported by the United States’ National Institutes of Health (NIH) is best known. Between 2007 and 2016, NIH invested a total of $ 215 million in HMP (Proctor, <xref ref-type="bibr" rid="CR72">2019</xref>), with an additional $ 728 million for other human microbiome studies from 2012 to 2016 (NIH Human Microbiome Portfolio Analysis Team, <xref ref-type="bibr" rid="CR101">2019</xref>). China, the United Kingdom, Germany, Canada, France, and other countries and regions also continue to increase investment. It is estimated that the global investment in microbiome-related research over the past decade has exceeded $ 1.7 billion (Proctor, <xref ref-type="bibr" rid="CR72">2019</xref>).</p>
<p id="Par10">At the same time, industrialization and commercialization of gut microbiome-related application is also progressing. The establishment of related biotechnology companies has sprung up, with considerable global investment. As of 2019, more than $ 3 billion has been invested in gut microbiome-related innovation companies. Similar to basic research, the United States took the lead with more than $ 2.4 billion in investment, and other countries are catching up (Fig. <xref ref-type="fig" rid="Fig3">3</xref>).<fig id="Fig3"><label>Figure 3</label><caption><p><bold>Financing of gut microbiota-related companies in different countries (from public data)</bold></p></caption><graphic id="MO3" xlink:href="13238_2020_697_Fig3_HTML"></graphic></fig></p>
</sec>
<sec id="Sec3">
<title>FACT 3. THE GUT MICROBIOME CONTRIBUTES TO HEALTH AND DISEASES</title>
<p id="Par11">The pivotal role of the gastrointestinal (GI) tract in health forms the basis for the gut microbiome to participate in host physiological processes and even affect human health and disease (Goldszmid and Trinchieri, <xref ref-type="bibr" rid="CR33">2012</xref>). Besides its role in the digestion, absorption, and metabolism of food and nutrients, the gut is an important immune and endocrine organ (Rehfeld, <xref ref-type="bibr" rid="CR76">1998</xref>; Weiner et al., <xref ref-type="bibr" rid="CR112">2011</xref>; Gribble and Reimann, <xref ref-type="bibr" rid="CR36">2019</xref>). In addition, it is also known as “the second brain” with a complex enteric nervous system which communicates with the brain via the vagus nerve (Mayer, <xref ref-type="bibr" rid="CR58">2011</xref>; Avetisyan et al., <xref ref-type="bibr" rid="CR3">2015</xref>; Yoo and Mazmanian, <xref ref-type="bibr" rid="CR115">2017</xref>).</p>
<p id="Par12">Gut microbiome studies are now transforming from correlation to causation, with the efforts to address the mechanisms by which the microbiome influences host health (Gilbert et al., <xref ref-type="bibr" rid="CR32">2018</xref>; Schmidt et al., <xref ref-type="bibr" rid="CR85">2018</xref>). In their <italic>Nature</italic> paper published in 2006, by using fecal microbiota transplantation in mice, the Gordon lab demonstrated for the first time that host obesity phenotype can be affected and transmitted by the gut microbiome (Turnbaugh et al., <xref ref-type="bibr" rid="CR106">2006</xref>).</p>
<p id="Par13">Since then, growing evidence confirms that the gut microbiome can be considered the “microbial organ” of the body (O’Hara and Shanahan, <xref ref-type="bibr" rid="CR67">2006</xref>; Byndloss and Bäumler, <xref ref-type="bibr" rid="CR9">2018</xref>), acting through multiple mechanisms (e.g., microbiota-derived metabolites (Schroeder and Bäckhed, <xref ref-type="bibr" rid="CR86">2016</xref>; Dalile et al., <xref ref-type="bibr" rid="CR18">2019</xref>) and microbial translocation (Manfredo Vieira et al., <xref ref-type="bibr" rid="CR57">2018</xref>; Meisel et al., <xref ref-type="bibr" rid="CR59">2018</xref>)) to communicate with the host and regulate host physiology at both local and systemic levels. It is believed that the gut microbiome can affect host metabolism (Tilg et al., <xref ref-type="bibr" rid="CR104">2020</xref>), immunity (Belkaid and Harrison, <xref ref-type="bibr" rid="CR6">2017</xref>), endocrine (Rooks and Garrett, <xref ref-type="bibr" rid="CR81">2016</xref>; Rastelli et al., <xref ref-type="bibr" rid="CR75">2019</xref>), and neural function (Sharon et al., <xref ref-type="bibr" rid="CR92">2016</xref>) and thus contribute to host susceptibility to a series of diseases (Sekirov et al., <xref ref-type="bibr" rid="CR88">2010</xref>; Clemente et al., <xref ref-type="bibr" rid="CR12">2012</xref>; Nicholson et al., <xref ref-type="bibr" rid="CR64">2012</xref>; Lynch and Pedersen <xref ref-type="bibr" rid="CR56">2016</xref>), such as obesity (Le Chatelier et al., <xref ref-type="bibr" rid="CR53">2013</xref>; Ridaura et al., <xref ref-type="bibr" rid="CR80">2013</xref>), diabetes (Qin et al., <xref ref-type="bibr" rid="CR73">2012</xref>), fatty liver diseases (Canfora et al., <xref ref-type="bibr" rid="CR10">2019</xref>), cardiovascular diseases (Schiattarella et al., <xref ref-type="bibr" rid="CR83">2017</xref>), autoimmune and inflammatory diseases (Clemente et al., <xref ref-type="bibr" rid="CR13">2018</xref>), psychological and neurological disorders (Cryan et al., <xref ref-type="bibr" rid="CR17">2020</xref>), and cancer (Garrett, <xref ref-type="bibr" rid="CR28">2015</xref>; Yu and Schwabe, <xref ref-type="bibr" rid="CR116">2017</xref>; Vitiello et al., <xref ref-type="bibr" rid="CR111">2019</xref>).</p>
<p id="Par14">In addition to the discovery of pathology and disease mechanisms, gut microbiome research also promotes the development of novel diagnosis and therapeutic interventions (Gilbert et al., <xref ref-type="bibr" rid="CR32">2018</xref>).</p>
<p id="Par15">Gut microbiota-related biomarkers can potentially be used for colorectal cancer and adenoma screening, and can increase the accuracy of current non-invasive screening methods when used combinedly (Wong and Yu, <xref ref-type="bibr" rid="CR113">2019</xref>). Restoration of the gut microbiome by fecal microbiota transplantation (FMT) has proven effective in treating recurrent <italic>C</italic>. <italic>difficile</italic> infection and is also a potential treatment for inflammatory bowel disease and other diseases (Vaughn et al., <xref ref-type="bibr" rid="CR109">2019</xref>). Dietary fiber intervention can improve type 2 diabetes through selectively promoting short-chain fatty acid-producing bacteria (Zhao et al., <xref ref-type="bibr" rid="CR121">2018</xref>); and microbiota-directed complementary food seems a promising approach for treating childhood undernutrition (Gehrig et al., <xref ref-type="bibr" rid="CR29">2019</xref>).</p>
<p id="Par16">The gut microbiome is also a key factor in personalized medicine. For example, a machine-learning algorithm that integrates gut microbiota and other anthropometric parameters can predict personalized postprandial glycemic response (Zeevi et al., <xref ref-type="bibr" rid="CR118">2015</xref>). In addition, targeting specific overgrowing pathobiont is a promising strategy to treat the corresponding disease (Duan et al., <xref ref-type="bibr" rid="CR23">2019</xref>; Yuan et al., <xref ref-type="bibr" rid="CR117">2019</xref>).</p>
<p id="Par17">Furthermore, gut microbiome can also influence the effect of drugs and therapies by participating in drug metabolism and affecting host immune response (Skelly et al., <xref ref-type="bibr" rid="CR97">2019</xref>; Zimmermann et al., <xref ref-type="bibr" rid="CR122">2019a</xref>, <xref ref-type="bibr" rid="CR123">b</xref>); and it has been shown that lab animals that are too “clean” are not optimal models for drug development (Rosshart et al., <xref ref-type="bibr" rid="CR82">2019</xref>).</p>
</sec>
<sec id="Sec4">
<title>FACT 4. GUT DYSBIOSIS IS ONLY ONE FACTOR IN DISEASE</title>
<p id="Par18">Although plenty of work has shown that the gut microbiome plays a crucial role in human health, other factors, such as genetics, environmental exposure, and lifestyle, can also influence disease risk (Franks and McCarthy, <xref ref-type="bibr" rid="CR26">2016</xref>; Hall et al., <xref ref-type="bibr" rid="CR38">2017</xref>; Gentile and Weir, <xref ref-type="bibr" rid="CR30">2018</xref>; Scott et al., <xref ref-type="bibr" rid="CR87">2019</xref>). It has been speculated that, in some cases, gut microbiome abnormality may be not the root cause of disease but rather a mediating factor or a bystander (Hanage, <xref ref-type="bibr" rid="CR39">2014</xref>; Franks and McCarthy, <xref ref-type="bibr" rid="CR26">2016</xref>; Crow, <xref ref-type="bibr" rid="CR16">2018</xref>; Inamo, <xref ref-type="bibr" rid="CR42">2019</xref>; Jia et al., <xref ref-type="bibr" rid="CR45">2019</xref>).</p>
<p id="Par19">For diabetes, obesity, and other metabolic diseases that are closely related to the gut microbiome (Qin et al., <xref ref-type="bibr" rid="CR73">2012</xref>; Le Chatelier et al., <xref ref-type="bibr" rid="CR53">2013</xref>; Ridaura et al., <xref ref-type="bibr" rid="CR80">2013</xref>; Komaroff, <xref ref-type="bibr" rid="CR51">2017</xref>; Schiattarella et al., <xref ref-type="bibr" rid="CR83">2017</xref>), it is still unclear how much the microbiome contributes to disease initiation and progression. The development of these diseases is more likely a combined result of different driving factors (Keith et al., <xref ref-type="bibr" rid="CR47">2006</xref>; Franks and McCarthy, <xref ref-type="bibr" rid="CR26">2016</xref>; Chatterjee et al., <xref ref-type="bibr" rid="CR11">2017</xref>), including genetic susceptibility, dietary habits, physical activity, early life influences, sleep, and medication.</p>
<p id="Par20">Food allergy is another condition that correlates with changes in the gut microbiome (Iweala and Nagler, <xref ref-type="bibr" rid="CR44">2019</xref>). There are reports that microbiome-based interventions, such as probiotics, prebiotics, and fecal microbiota transplantation, may help reduce symptoms (Bunyavanich, <xref ref-type="bibr" rid="CR8">2019</xref>). However, the risk of allergic disease is also influenced by a series of factors (Iweala and Nagler, <xref ref-type="bibr" rid="CR44">2019</xref>). In addition to genetic predisposition, other early life factors including caesarean section, preterm birth, antibiotic usage, environmental pollution, infections, and maternal smoking and excessive drinking can all contribute to the development of food allergy (Reynolds and Finlay, <xref ref-type="bibr" rid="CR77">2017</xref>; Mitselou et al., <xref ref-type="bibr" rid="CR61">2018</xref>; Levin et al., <xref ref-type="bibr" rid="CR54">2019</xref>) and need to be considered for disease prevention and treatment (Tordesillas et al., <xref ref-type="bibr" rid="CR105">2017</xref>).</p>
<p id="Par21">When talking about gut microbiome-associated diseases, such as diarrhea (Singh et al., <xref ref-type="bibr" rid="CR95">2018</xref>), inflammatory bowel disease (Piovani et al., <xref ref-type="bibr" rid="CR70">2019</xref>), irritable bowel syndrome (Ford et al., <xref ref-type="bibr" rid="CR25">2017</xref>), cardiovascular disease (Miller et al., <xref ref-type="bibr" rid="CR60">2017</xref>), autism (Bai et al., <xref ref-type="bibr" rid="CR4">2019</xref>), Alzheimer’s disease (Kivipelto et al., <xref ref-type="bibr" rid="CR48">2018</xref>), Parkinson’s disease (Ascherio and Schwarzschild, <xref ref-type="bibr" rid="CR2">2016</xref>), it is important to keep in mind that the gut microbiome is only one aspect of the disease, and we should avoid overemphasizing its importance.</p>
</sec>
<sec id="Sec5">
<title>FACT 5: GUT MICROBIOME RESEARCH IS STILL AT ITS INFANCY</title>
<p id="Par22">What we know so far about gut microbiome might still just be the tip of the iceberg, and many limitations, inconclusive findings and controversies still exist within this field.</p>
<p id="Par23">Inter-personal gut microbiome is highly individualized, and even within the same individual, gut microbiome is highly dynamic within short term, thus we still lack a good definition of “healthy microbiome”. This missing baseline data or definition also hinders many of the translational and interventional research (Lloyd-Price et al., <xref ref-type="bibr" rid="CR55">2016</xref>).</p>
<p id="Par24">Besides bacteria, we also need to consider the impact of phages (Shkoporov and Hill, <xref ref-type="bibr" rid="CR94">2019</xref>), archaea (Pennisi <xref ref-type="bibr" rid="CR69">2017</xref>) and fungi (Richard and Sokol, <xref ref-type="bibr" rid="CR79">2019</xref>) in the GI tract on host health and diseases. Researches into those topics are still at a relative early stage. How do we study their function and potential roles of vast unknown and/or uncultured microbes? Metagenomics and culturomics are improving constantly and facilitate such analyses, yet many remain to be done (Nayfach et al., <xref ref-type="bibr" rid="CR63">2019</xref>).</p>
<p id="Par25">Also, can animal studies be translated directly to humans? Probably not, as recently the US firm Synlogic has created an engineered bacteria strain and treated phenylketonuria in mouse models (Isabella et al., <xref ref-type="bibr" rid="CR43">2018</xref>), yet it failed in the human clinical trial, suggesting a direct and simple translation is not feasible.</p>
<p id="Par26">How to resolve the standardization and repeatability issues in microbiome research? Such essential issues call for even more scientists to work at a global scale for standardization in methodology and more open databases to be shared among researchers (Servick, <xref ref-type="bibr" rid="CR89">2016</xref>; Costea et al., <xref ref-type="bibr" rid="CR15">2017</xref>; Poussin et al., <xref ref-type="bibr" rid="CR71">2018</xref>; Schloss, <xref ref-type="bibr" rid="CR84">2018</xref>).</p>
<p id="Par27">How about long-term safety in microbiome intervention approaches such as prebiotics, probiotics and fecal-material transplantation? Recent researches have indicated that many of the interventions carry potential risks (Singh et al., <xref ref-type="bibr" rid="CR96">2018</xref>; Suez et al., <xref ref-type="bibr" rid="CR100">2018</xref>; DeFilipp et al., <xref ref-type="bibr" rid="CR20">2019</xref>; Yelin et al., <xref ref-type="bibr" rid="CR114">2019</xref>). And how do we manipulate microbiome with precision? One example might be personalized nutrition research and translation (Zmora et al., <xref ref-type="bibr" rid="CR124">2016</xref>; Johnson et al., <xref ref-type="bibr" rid="CR46">2019</xref>) and it has gained attention, yet this has to be done on large number of individuals and to be tracked over a longer time.</p>
<p id="Par28">Thus, it is fair to conclude that microbiome research is still in its infancy, more thorough research with better methods has to be carried out to determine the role as well as mechanisms of gut microbiome in human health and diseases, plus the efficacy and safety of interventional approaches.</p>
</sec>
<sec id="Sec6">
<title>FACT 6: CHAOS AND CONFLICT OF INTEREST EXIST IN GUT MICROBIOME RESEARCH</title>
<p id="Par29">Due to inappropriate self-publicity and interpretation of certain researchers, combined with the further exaggeration of many media and commercial partners, many of the gut microbiome research results and microbiome-based research products have been labeled erroneously to be the new panacea, capable of treating all kinds of illness. This idea was even adopted by many of the radical researchers. Such extreme kind of concept is for sure detrimental for the gut microbiome research and industry.</p>
<p id="Par30">Currently, the golden standard for evaluating drug safety and efficacy is randomized, controlled clinical trials (Bothwell and Podolsky, <xref ref-type="bibr" rid="CR7">2016</xref>; Djulbegovic and Guyatt, <xref ref-type="bibr" rid="CR21">2017</xref>), which has also been used to evaluate gut microbiome related interventions. Yet in reality, randomized controlled trials (RCTs) are limited by individual differences, short term of intervention etc when it comes to evaluating prebiotics and probiotics (Zeilstra et al., <xref ref-type="bibr" rid="CR119">2018</xref>), and functional evidence is also limited to deepen the insights into mechanisms (Guarino and Canani, <xref ref-type="bibr" rid="CR37">2016</xref>).</p>
<p id="Par31">In such context, exaggeration of the probiotics’ efficacy, misplacing the function of whole gut microbiome by just a few products, and abuse of research products, as well as ignoring the complexity of gut microbiome by over-simplifying study design and interventional approaches are among the common phenomena in this field (Crow, <xref ref-type="bibr" rid="CR16">2018</xref>).</p>
<p id="Par32">In addition, in commercial activities there are cases of promoting probiotics towards immune-deficient populations, which is potentially risky (Cohen, <xref ref-type="bibr" rid="CR14">2018</xref>). In fact, special population including ICU patients (Yelin et al., <xref ref-type="bibr" rid="CR114">2019</xref>) and hospitalized elderly (Dauby, <xref ref-type="bibr" rid="CR19">2017</xref>) are at risk of bacteraemia when intake probiotics, and in extreme cases, immune-deficient elderly could develop hepatapostema and bacteraemia after long-term ingestion of yogurts (Pararajasingam and Uwagwu, <xref ref-type="bibr" rid="CR68">2017</xref>).</p>
<p id="Par33">Also, when the essential question remains unanswered regarding the baseline healthy microbiome’s characteristics, the concept of gut microbiome dysregulation or dysbiosis has been abused, to lure the consumers and patients to purchase microbiome-related products (Shanahan and Hill, <xref ref-type="bibr" rid="CR91">2019</xref>).</p>
<p id="Par34">Besides, we need to be alerted by the conflict of commercial interests within research. For instance, food industry sponsored nutritional research (Mozaffarian, <xref ref-type="bibr" rid="CR62">2017</xref>), or even those by public health research organization (Galea and Saitz, <xref ref-type="bibr" rid="CR27">2017</xref>), professional associations or societies (Nissen, <xref ref-type="bibr" rid="CR65">2017</xref>), those who set the standards (Sox, <xref ref-type="bibr" rid="CR98">2017</xref>) all could be affected by different interests (Greenhalgh, <xref ref-type="bibr" rid="CR35">2019</xref>). Nutritional analyses and meta-analyses might also be manipulated to cover the negative effects of certain products (Barnard et al., <xref ref-type="bibr" rid="CR5">2017</xref>).</p>
<p id="Par35">Under such circumstances, many of the claims by infant dairy products including promoting cognitive capacity and safeguarding intestinal health lack sufficient scientific evidence (Hughes et al., <xref ref-type="bibr" rid="CR41">2017</xref>). Yet how to regulate such issues remains a difficult task for regulatory bodies including the US FDA (The Lancet null, <xref ref-type="bibr" rid="CR102">2019</xref>).</p>
</sec>
<sec id="Sec7">
<title>FACT 7: SELF-PURIFICATION AND DISCIPLINE MECHANISMS EXIST IN GUT MICROBIOME RESEARCH</title>
<p id="Par36">Many of experts in this field have realized that the recent zealousness might lead to a topic bubble, and the call for strengthening self-purification and discipline also gained support, with a few such recommendations being issued via scientific journals.</p>
<p id="Par37">First of all, experts call for the principle of caution and critics regarding microbiome research (Hanage, <xref ref-type="bibr" rid="CR39">2014</xref>; Crow, <xref ref-type="bibr" rid="CR16">2018</xref>). For instance, the description of research results has to be accurate and faithful, and avoid over-interpretation regarding non-causal studies as well as animal studies. While accumulating evidence over causality, we also need to deepen the microbiome research into the level of bacterial strains and bacterial genes, to gain insights onto the exact mechanisms (Fischbach, <xref ref-type="bibr" rid="CR24">2018</xref>). This is particularly important for the field of probiotics (Kleerebezem et al., <xref ref-type="bibr" rid="CR49">2019</xref>). Plus, researchers are also working on the standardization of procedure and methodology in microbiome research (Knight et al., <xref ref-type="bibr" rid="CR50">2018</xref>).</p>
<p id="Par38">Another new task is to regulate effectively all the diverse upcoming approaches in microbiome intervention (Aagaard and Hohmann, <xref ref-type="bibr" rid="CR1">2019</xref>). Many recommendations were issued regarding interventional approaches including probiotics with potential risks (Cohen, <xref ref-type="bibr" rid="CR14">2018</xref>) and FMT (Hoffmann et al., <xref ref-type="bibr" rid="CR40">2017</xref>; Verbeke et al., <xref ref-type="bibr" rid="CR110">2017</xref>), as well as novel food products targeting microbiome and aiming at microbiome health (Green et al., <xref ref-type="bibr" rid="CR34">2017</xref>).</p>
<p id="Par39">The public are expected to understand, appreciate and eventually participate into the microbiome research and translation, while the research and translation themselves have to effectively avoid risk and safety issues (Dominguez-Bello et al., <xref ref-type="bibr" rid="CR22">2016</xref>; Shamarina et al., <xref ref-type="bibr" rid="CR90">2017</xref>). It is widely accepted that ethics has to be obeyed during the process of research and translation (O’Doherty et al., <xref ref-type="bibr" rid="CR66">2016</xref>; Rhodes <xref ref-type="bibr" rid="CR78">2016</xref>).</p>
<p id="Par40">It is not without solution when it comes to the complex, multi-faceted conflict of interests issues, as pointed out by scholars (Stead, <xref ref-type="bibr" rid="CR99">2017</xref>). For instance, many of the recommendations have been made that the health policy making process should not be influenced by food industries’ interests (Untangle food industry influences on health <xref ref-type="bibr" rid="CR107">2019</xref>), scientific researchers should disclose actively and fully their own potential conflict of interest (Thornton, <xref ref-type="bibr" rid="CR103">2017</xref>), and medical professionals should disclose such conflicts to patients as well (Zuger, <xref ref-type="bibr" rid="CR125">2017</xref>).</p>
<p id="Par41">Thus, it is obvious that a fully functioning self-purification and discipline mechanism has been established among the scientific bodies of microbiome researchers, covering the design and execution of research, means of regulation and biological ethics.</p>
</sec>
<sec id="Sec8">
<title>FIVE INITIATIVES</title>
<p id="Par42">Based on the above 7 facts about gut microbiome, in particular, we propose below five initiatives for basic researchers, clinicians, and industrial professionals in relevant fields:</p>
<sec id="Sec9">
<title>Follow the normative ethical principles to carry out research</title>
<p id="Par43">We propose that research activities related to gut microbiome should be subject to necessary ethical review and peer review.</p>
<p id="Par44">Researchers should learn, practice and respect bioethical principles, adhere to scientific spirit, scientific culture and research ethics; on the basis of truth-seeking and rational criticism, researchers should strive to be innovative and responsible; researchers should adjust the relationship between themselves and collaborators (including other researchers, funders, research subjects, general public/consumers) and objects (including experimental animals, ecological environment, etc.) in a timely manner, and also take social responsibility.</p>
</sec>
<sec id="Sec10">
<title>Avoid hype and packaging</title>
<p id="Par45">We propose that basic researchers, clinicians, industry and media professionals should avoid hype and over-promoting/packaging of gut microbiome and themselves, and actively participate in self-discipline and self-purifying in the whole field.</p>
<p id="Par46">Researchers should avoid using their affiliated insititutions, and their position endorsement to create personal influence, refrain from self-marketing, and also avoid exaggerating or over-promoting individual or team’s research results. In the publicity work of scientific research, industry, and social media, we should avoid the labeling gut microbiome as “panacea” or “useless”; we oppose opportunism, clickbait, and sensationalising the hot topic; we oppose the “vulgarization” and “pseudoscientization” of gut microbiome research, including the abuse of the concept of “gut microbiome” to irrelevant fields, or promise unrealistic effects, etc.</p>
</sec>
<sec id="Sec11">
<title>Disclose conflict of interest and reveal safety and risk issues actively</title>
<p id="Par47">We propose that researchers actively disclose the conflict of interest in various occasions, such as publishing papers, academic speeches, media publicity, etc., and at the same time, if there are potential safety risks in related products and services, they should proactively inform consumers or patients.</p>
<p id="Par48">In both research and translational application, it is important to maintain openness and transparency during risk recognition, assessment, risk management and damage control. Researchers actively disclose conflict of interest would not only be beneficial for individuals, but also for the brand accumulated value and dissemination of products and/or services. Meanwhile, if researchers can actively inform patients/ consumers about the safety risks, this will also increase brand trusts and credibility of individuals, products or services, and effectively avoid bringing risks to consumers/patients, thus reducing the systematic risks of whole industry.</p>
</sec>
<sec id="Sec12">
<title>Abide by laws and disciplines and adhere to evidence-based scientific rules</title>
<p id="Par49">We propose to strictly abide by national laws and regulations and adhere to evidence-based scientific rules in the process of industrialization. The function, efficacy, and health benefit claims of a specific product or service must comply with the relevant national laws and regulations, and must never break the legal and ethical bottom line. The promotion of function and efficacy of a particular products or services should be based on high-quality evidence, and the evidence of RCT should be developed and accumulated. We should not over-interpret the results generated from cell and animal experiments, whereas also pay special attention to the risks of side effects and unintended consequences.</p>
</sec>
<sec id="Sec13">
<title>Actively participate in science popularization and education and promote public participation</title>
<p id="Par50">We call on professionals to actively participate in science popularization, dissemination and education activities for the public, meanwhile also consciously absorb public opinions and encourage the public to participate in and contribute to scientific research equally.</p>
<p id="Par51">In the face of the rapid development of gut microbiome research and fast growing of knowledge update and accumulation, there are a mix of hope, help, and hype, which sometimes make people confused. Furthermore, the area of gut microbiome is increasingly influenced and even dominated by commercial market and capitals, which may put public interest at stake. Therefore, established and mainstream front-line experts are urgently needed to participate in popular science activities. In the daily science communication work, professionals can systematically popularize the relevant knowledge of gut microbiota, whereas in case of big events, they should respond to the public’s concerns in a timely and transparent manner and ultimately to achieve a responsible and sustainable supportive environment for research.
</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGEMENTS</title>
<p>This work was supported by National Key Research and Development Program of China (2018YFC2000500), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29020000), the National Natural Science Foundation of China (31771481, 91857101), and the National Social Science Foundation of China (16CZX064). We thank Prof. Liping Zhao from Shanghai Jiao Tong University for insightful advice and the many researchers, clinicians and industry specialists who participated in the discussion and provided valuable suggestions.</p>
<sec id="FPar1">
<title>Abbreviations</title>
<p id="Par52">FDA, Food and Drug Administration; FMT, fecal microbiota transplantation; HMP, Human Microbiome Project; ICU, intensive care unit; NIH, National Institutes of Health; RCT, randomized controlled trial.</p>
</sec>
<sec id="FPar2">
<title>Compliance with ethics guidelines</title>
<p id="Par53">Danyi Li, Chunhui Gao, Faming Zhang, Ruifu Yang, Canhui Lan, Yonghui Ma, and Jun Wang declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects performed by any of the authors.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aagaard</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hohmann</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Regulating microbiome manipulation</article-title>
<source/>Nat Med
          <year>2019</year>
<volume>25</volume>
<issue>6</issue>
<fpage>874</fpage>
<lpage>876</lpage>
<pub-id pub-id-type="pmid">31133692</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ascherio</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schwarzschild</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>The epidemiology of Parkinson’s disease: risk factors and prevention</article-title>
<source/>Lancet Neurol
          <year>2016</year>
<volume>15</volume>
<issue>12</issue>
<fpage>1257</fpage>
<lpage>1272</lpage>
<pub-id pub-id-type="pmid">27751556</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avetisyan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schill</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Heuckeroth</surname>
<given-names>RO</given-names>
</name>
</person-group>
<article-title>Building a second brain in the bowel</article-title>
<source/>J Clin Invest
          <year>2015</year>
<volume>125</volume>
<issue>3</issue>
<fpage>899</fpage>
<lpage>907</lpage>
<pub-id pub-id-type="pmid">25664848</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yip</surname>
<given-names>BHK</given-names>
</name>
<name>
<surname>Windham</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Sourander</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yoffe</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Glasson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mahjani</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Suominen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of genetic and environmental factors with autism in a 5-country cohort</article-title>
<source/>JAMA Psychiatry
          <year>2019</year>
<volume>76</volume>
<fpage>1035</fpage>
<lpage>1043</lpage>
<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2019.1411</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnard</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Willett</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>EL</given-names>
</name>
</person-group>
<article-title>The misuse of meta-analysis in nutrition research</article-title>
<source/>JAMA
          <year>2017</year>
<volume>318</volume>
<issue>15</issue>
<fpage>1435</fpage>
<lpage>1436</lpage>
<pub-id pub-id-type="pmid">28975260</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belkaid</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>OJ</given-names>
</name>
</person-group>
<article-title>Homeostatic immunity and the microbiota</article-title>
<source/>Immunity
          <year>2017</year>
<volume>46</volume>
<issue>4</issue>
<fpage>562</fpage>
<lpage>576</lpage>
<pub-id pub-id-type="pmid">28423337</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bothwell</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Podolsky</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>The emergence of the randomized, controlled trial</article-title>
<source/>N Engl J Med
          <year>2016</year>
<volume>375</volume>
<issue>6</issue>
<fpage>501</fpage>
<lpage>504</lpage>
<pub-id pub-id-type="pmid">27509097</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bunyavanich</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Food allergy: could the gut microbiota hold the key?</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2019</year>
<volume>16</volume>
<issue>4</issue>
<fpage>201</fpage>
<lpage>202</lpage>
<pub-id pub-id-type="pmid">30824883</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byndloss</surname>
<given-names>MX</given-names>
</name>
<name>
<surname>Bäumler</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>The germ-organ theory of non-communicable diseases</article-title>
<source/>Nat Rev Microbiol
          <year>2018</year>
<volume>16</volume>
<issue>2</issue>
<fpage>103</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="pmid">29307890</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canfora</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Meex</surname>
<given-names>RCR</given-names>
</name>
<name>
<surname>Venema</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Blaak</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Gut microbial metabolites in obesity, NAFLD and T2DM</article-title>
<source/>Nat Rev Endocrinol
          <year>2019</year>
<volume>15</volume>
<issue>5</issue>
<fpage>261</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="pmid">30670819</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chatterjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Khunti</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Type 2 diabetes</article-title>
<source/>Lancet Lond Engl
          <year>2017</year>
<volume>389</volume>
<issue>10085</issue>
<fpage>2239</fpage>
<lpage>2251</lpage>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clemente</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Ursell</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Parfrey</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The impact of the gut microbiota on human health: an integrative view</article-title>
<source/>Cell
          <year>2012</year>
<volume>148</volume>
<issue>6</issue>
<fpage>1258</fpage>
<lpage>1270</lpage>
<pub-id pub-id-type="pmid">22424233</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clemente</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Manasson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Scher</surname>
<given-names>JU</given-names>
</name>
</person-group>
<article-title>The role of the gut microbiome in systemic inflammatory disease</article-title>
<source/>BMJ
          <year>2018</year>
<volume>360</volume>
<fpage>j5145</fpage>
<pub-id pub-id-type="pmid">29311119</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Probiotic safety-no guarantees</article-title>
<source/>JAMA Intern Med
          <year>2018</year>
<volume>178</volume>
<issue>12</issue>
<fpage>1577</fpage>
<lpage>1578</lpage>
<pub-id pub-id-type="pmid">30242393</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costea</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Zeller</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sunagawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pelletier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Alberti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Levenez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tramontano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Driessen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hercog</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>F-E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Towards standards for human fecal sample processing in metagenomic studies</article-title>
<source/>Nat Biotechnol
          <year>2017</year>
<volume>35</volume>
<issue>11</issue>
<fpage>1069</fpage>
<lpage>1076</lpage>
<pub-id pub-id-type="pmid">28967887</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crow</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Microbiome research in a social world</article-title>
<source/>Cell
          <year>2018</year>
<volume>172</volume>
<issue>6</issue>
<fpage>1143</fpage>
<lpage>1145</lpage>
<pub-id pub-id-type="pmid">29522731</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cryan</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>O’Riordan</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Sandhu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>TG</given-names>
</name>
</person-group>
<article-title>The gut microbiome in neurological disorders</article-title>
<source/>Lancet Neurol
          <year>2019</year>
<volume>19</volume>
<issue>2</issue>
<fpage>179</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="pmid">31753762</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dalile</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Van Oudenhove</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vervliet</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Verbeke</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>The role of short-chain fatty acids in microbiota-gut-brain communication</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2019</year>
<volume>16</volume>
<issue>8</issue>
<fpage>461</fpage>
<lpage>478</lpage>
<pub-id pub-id-type="pmid">31123355</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dauby</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Risks of <italic>Saccharomyces boulardii</italic>-containing probiotics for the prevention of clostridium difficile infection in the elderly</article-title>
<source/>Gastroenterology
          <year>2017</year>
<volume>153</volume>
<issue>5</issue>
<fpage>1450</fpage>
<lpage>1451</lpage>
<pub-id pub-id-type="pmid">28988917</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeFilipp</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Bloom</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Torres Soto</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Drug-resistant <italic>E. coli</italic> bacteremia transmitted by fecal microbiota transplant</article-title>
<source/>N Engl J Med
          <year>2019</year>
<volume>381</volume>
<issue>21</issue>
<fpage>2043</fpage>
<lpage>2050</lpage>
<pub-id pub-id-type="pmid">31665575</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Djulbegovic</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Guyatt</surname>
<given-names>GH</given-names>
</name>
</person-group>
<article-title>Progress in evidence-based medicine: a quarter century on</article-title>
<source/>Lancet Lond Engl
          <year>2017</year>
<volume>390</volume>
<issue>10092</issue>
<fpage>415</fpage>
<lpage>423</lpage>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominguez-Bello</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Noya-Alarcon</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ethics of exploring the microbiome of native peoples</article-title>
<source/>Nat Microbiol
          <year>2016</year>
<volume>1</volume>
<issue>7</issue>
<fpage>16097</fpage>
<pub-id pub-id-type="pmid">27572978</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Llorente</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brandl</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>White</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Torralba</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease</article-title>
<source/>Nature
          <year>2019</year>
<volume>575</volume>
<issue>7783</issue>
<fpage>505</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="pmid">31723265</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischbach</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Microbiome: focus on causation and mechanism</article-title>
<source/>Cell
          <year>2018</year>
<volume>174</volume>
<issue>4</issue>
<fpage>785</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="pmid">30096310</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ford</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Lacy</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Talley</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>Irritable bowel syndrome</article-title>
<source/>N Engl J Med
          <year>2017</year>
<volume>376</volume>
<issue>26</issue>
<fpage>2566</fpage>
<lpage>2578</lpage>
<pub-id pub-id-type="pmid">28657875</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franks</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>MI</given-names>
</name>
</person-group>
<article-title>Exposing the exposures responsible for type 2 diabetes and obesity</article-title>
<source/>Science
          <year>2016</year>
<volume>354</volume>
<issue>6308</issue>
<fpage>69</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="pmid">27846494</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galea</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Saitz</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Funding, institutional conflicts of interest, and schools of public health: realities and solutions</article-title>
<source/>JAMA
          <year>2017</year>
<volume>317</volume>
<issue>17</issue>
<fpage>1735</fpage>
<lpage>1736</lpage>
<pub-id pub-id-type="pmid">28464147</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garrett</surname>
<given-names>WS</given-names>
</name>
</person-group>
<article-title>Cancer and the microbiota</article-title>
<source/>Science
          <year>2015</year>
<volume>348</volume>
<issue>6230</issue>
<fpage>80</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">25838377</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gehrig</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H-W</given-names>
</name>
<name>
<surname>Hibberd</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Kung</surname>
<given-names>VL</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>RY</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cowardin</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Meier</surname>
<given-names>MF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of microbiota-directed foods in gnotobiotic animals and undernourished children</article-title>
<source/>Science
          <year>2019</year>
<volume>365</volume>
<issue>6449</issue>
<fpage>eaau4732</fpage>
<pub-id pub-id-type="pmid">31296738</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gentile</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Weir</surname>
<given-names>TL</given-names>
</name>
</person-group>
<article-title>The gut microbiota at the intersection of diet and human health</article-title>
<source/>Science
          <year>2018</year>
<volume>362</volume>
<issue>6416</issue>
<fpage>776</fpage>
<lpage>780</lpage>
<pub-id pub-id-type="pmid">30442802</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Debelius</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>ZZ</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jansson</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Dorrestein</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Microbiome-wide association studies link dynamic microbial consortia to disease</article-title>
<source/>Nature
          <year>2016</year>
<volume>535</volume>
<issue>7610</issue>
<fpage>94</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="pmid">27383984</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Blaser</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Caporaso</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Jansson</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Current understanding of the human microbiome</article-title>
<source/>Nat Med
          <year>2018</year>
<volume>24</volume>
<issue>4</issue>
<fpage>392</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="pmid">29634682</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldszmid</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Trinchieri</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The price of immunity</article-title>
<source/>Nat Immunol
          <year>2012</year>
<volume>13</volume>
<issue>10</issue>
<fpage>932</fpage>
<lpage>938</lpage>
<pub-id pub-id-type="pmid">22990891</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Green</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Barratt</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kinch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>Food and microbiota in the FDA regulatory framework</article-title>
<source/>Science
          <year>2017</year>
<volume>357</volume>
<issue>6346</issue>
<fpage>39</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="pmid">28684495</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenhalgh</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Making China safe for coke: how Coca-Cola shaped obesity science and policy in China</article-title>
<source/>BMJ
          <year>2019</year>
<volume>364</volume>
<fpage>k5050</fpage>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gribble</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Reimann</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Function and mechanisms of enteroendocrine cells and gut hormones in metabolism</article-title>
<source/>Nat Rev Endocrinol
          <year>2019</year>
<volume>15</volume>
<issue>4</issue>
<fpage>226</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="pmid">30760847</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guarino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Canani</surname>
<given-names>RB</given-names>
</name>
</person-group>
<article-title>Probiotics in childhood diseases: from basic science to guidelines in 20 years of research and development</article-title>
<source/>J Pediatr Gastroenterol Nutr
          <year>2016</year>
<volume>63</volume>
<issue>Suppl 1</issue>
<fpage>S1</fpage>
<lpage>S2</lpage>
<pub-id pub-id-type="pmid">27380590</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Tolonen</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Human genetic variation and the gut microbiome in disease</article-title>
<source/>Nat Rev Genet
          <year>2017</year>
<volume>18</volume>
<issue>11</issue>
<fpage>690</fpage>
<lpage>699</lpage>
<pub-id pub-id-type="pmid">28824167</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanage</surname>
<given-names>WP</given-names>
</name>
</person-group>
<article-title>Microbiology: microbiome science needs a healthy dose of scepticism</article-title>
<source/>Nature
          <year>2014</year>
<volume>512</volume>
<issue>7514</issue>
<fpage>247</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="pmid">25143098</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Palumbo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ravel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Roghmann</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Rowthorn</surname>
<given-names>V</given-names>
</name>
<name>
<surname>von Rosenvinge</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Improving regulation of microbiota transplants</article-title>
<source/>Science
          <year>2017</year>
<volume>358</volume>
<issue>6369</issue>
<fpage>1390</fpage>
<lpage>1391</lpage>
<pub-id pub-id-type="pmid">29242336</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Landa</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Sharfstein</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Marketing claims for infant formula: the need for evidence</article-title>
<source/>JAMA Pediatr
          <year>2017</year>
<volume>171</volume>
<issue>2</issue>
<fpage>105</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="pmid">28027329</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inamo</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study</article-title>
<source/>Ann Rheum Dis
          <year>2019</year>
<pub-id pub-id-type="doi">10.1136/annrheumdis-2019-216565</pub-id>
<pub-id pub-id-type="pmid">31744823</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isabella</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Castillo</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Lubkowicz</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Rowe</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Millet</surname>
<given-names>YA</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>West</surname>
<given-names>KA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria</article-title>
<source/>Nat Biotechnol
          <year>2018</year>
<volume>36</volume>
<issue>9</issue>
<fpage>857</fpage>
<lpage>864</lpage>
<pub-id pub-id-type="pmid">30102294</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iweala</surname>
<given-names>OI</given-names>
</name>
<name>
<surname>Nagler</surname>
<given-names>CR</given-names>
</name>
</person-group>
<article-title>The microbiome and food allergy</article-title>
<source/>Annu Rev Immunol
          <year>2019</year>
<volume>37</volume>
<fpage>377</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="pmid">31026410</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Assessment of causal direction between gut microbiota-dependent metabolites and cardiometabolic health: a bidirectional mendelian randomization analysis</article-title>
<source/>Diabetes
          <year>2019</year>
<volume>68</volume>
<issue>9</issue>
<fpage>1747</fpage>
<lpage>1755</lpage>
<pub-id pub-id-type="pmid">31167879</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Vangay</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Al-Ghalith</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Hillmann</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Shields-Cutler</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>ShmagelAK</surname>
<given-names>Syed AN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Daily sampling reveals personalized diet-microbiome associations in humans</article-title>
<source/>Cell Host Microbe
          <year>2019</year>
<volume>25</volume>
<issue>6</issue>
<fpage>789</fpage>
<lpage>802.e5</lpage>
<pub-id pub-id-type="pmid">31194939</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keith</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Redden</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Katzmarzyk</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Boggiano</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Hanlon</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Benca</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Ruden</surname>
<given-names>D</given-names>
</name>
<name>
<surname>PietrobelliA</surname>
<given-names>Barger JL</given-names>
</name>
<name>
<surname>Fontaine</surname>
<given-names>KR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Putative contributors to the secular increase in obesity: exploring the roads less traveled</article-title>
<source/>Int J Obes 2005
          <year>2006</year>
<volume>30</volume>
<issue>11</issue>
<fpage>1585</fpage>
<lpage>1594</lpage>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kivipelto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mangialasche</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ngandu</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease</article-title>
<source/>Nat Rev Neurol
          <year>2018</year>
<volume>14</volume>
<issue>11</issue>
<fpage>653</fpage>
<lpage>666</lpage>
<pub-id pub-id-type="pmid">30291317</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleerebezem</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Binda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bron</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>C</given-names>
</name>
<name>
<surname>van Hylckama Vlieg</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Lebeer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Satokari</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ouwehand</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>Understanding mode of action can drive the translational pipeline towards more reliable health benefits for probiotics</article-title>
<source/>Curr Opin Biotechnol
          <year>2019</year>
<volume>56</volume>
<fpage>55</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">30296737</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vrbanac</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Aksenov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Callewaert</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Debelius</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kosciolek</surname>
<given-names>T</given-names>
</name>
<name>
<surname>McCall</surname>
<given-names>L-I</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Best practices for analysing microbiomes</article-title>
<source/>Nat Rev Microbiol
          <year>2018</year>
<volume>16</volume>
<issue>7</issue>
<fpage>410</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="pmid">29795328</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Komaroff</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>The microbiome and risk for obesity and diabetes</article-title>
<source/>JAMA
          <year>2017</year>
<volume>317</volume>
<issue>4</issue>
<fpage>355</fpage>
<lpage>356</lpage>
<pub-id pub-id-type="pmid">28006047</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lagier</surname>
<given-names>J-C</given-names>
</name>
<name>
<surname>Dubourg</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Million</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cadoret</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bilen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fenollar</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Levasseur</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rolain</surname>
<given-names>J-M</given-names>
</name>
<name>
<surname>FournierP-E</surname>
<given-names>Raoult D</given-names>
</name>
</person-group>
<article-title>Culturing the human microbiota and culturomics</article-title>
<source/>Nat Rev Microbiol
          <year>2018</year>
<volume>16</volume>
<fpage>540</fpage>
<lpage>550</lpage>
<pub-id pub-id-type="pmid">29937540</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Chatelier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Prifti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hildebrand</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Falony</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Arumugam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Batto</surname>
<given-names>J-M</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Richness of human gut microbiome correlates with metabolic markers</article-title>
<source/>Nature.
          <year>2013</year>
<volume>500</volume>
<issue>7464</issue>
<fpage>541</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="pmid">23985870</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levin</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Botha</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Basera</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Facey-Thomas</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Gaunt</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Kiragu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ramjith</surname>
<given-names>J</given-names>
</name>
<name>
<surname>WatkinsA</surname>
<given-names>Genuneit J</given-names>
</name>
</person-group>
<article-title>Environmental factors associated with allergy in urban and rural children from the South AFrican Food Allergy (SAFFA) cohort</article-title>
<source/>J Allergy Clin Immunol
          <year>2020</year>
<volume>145</volume>
<issue>1</issue>
<fpage>415</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="pmid">31606483</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lloyd-Price</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Abu-Ali</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Huttenhower</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The healthy human microbiome</article-title>
<source/>Genome Med
          <year>2016</year>
<volume>8</volume>
<issue>1</issue>
<fpage>51</fpage>
<pub-id pub-id-type="pmid">27122046</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lynch</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>The human intestinal microbiome in health and disease</article-title>
<source/>N Engl J Med
          <year>2016</year>
<volume>375</volume>
<issue>24</issue>
<fpage>2369</fpage>
<lpage>2379</lpage>
<pub-id pub-id-type="pmid">27974040</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manfredo Vieira</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hiltensperger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Zegarra-Ruiz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dehner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>FRC</given-names>
</name>
<name>
<surname>Tiniakou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Greiling</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ruff</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Translocation of a gut pathobiont drives autoimmunity in mice and humans</article-title>
<source/>Science
          <year>2018</year>
<volume>359</volume>
<issue>6380</issue>
<fpage>1156</fpage>
<lpage>1161</lpage>
<pub-id pub-id-type="pmid">29590047</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayer</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>Gut feelings: the emerging biology of gut-brain communication</article-title>
<source/>Nat Rev Neurosci
          <year>2011</year>
<volume>12</volume>
<issue>8</issue>
<fpage>453</fpage>
<lpage>466</lpage>
<pub-id pub-id-type="pmid">21750565</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meisel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hinterleitner</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pacis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Earley</surname>
<given-names>ZM</given-names>
</name>
<name>
<surname>Mayassi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pierre</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Ernest</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Galipeau</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Thuille</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host</article-title>
<source/>Nature
          <year>2018</year>
<volume>557</volume>
<issue>7706</issue>
<fpage>580</fpage>
<lpage>584</lpage>
<pub-id pub-id-type="pmid">29769727</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mente</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dehghan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rangarajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Swaminathan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dagenais</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mohan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lear</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study</article-title>
<source/>Lancet Lond Engl
          <year>2017</year>
<volume>390</volume>
<issue>10107</issue>
<fpage>2037</fpage>
<lpage>2049</lpage>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitselou</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hallberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stephansson</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Almqvist</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Melén</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ludvigsson</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Cesarean delivery, preterm birth, and risk of food allergy: nationwide Swedish cohort study of more than 1 million children</article-title>
<source/>J Allergy Clin Immunol
          <year>2018</year>
<volume>142</volume>
<issue>5</issue>
<fpage>1510</fpage>
<lpage>1514.e2</lpage>
<pub-id pub-id-type="pmid">30213656</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mozaffarian</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Conflict of interest and the role of the food industry in nutrition research</article-title>
<source/>JAMA
          <year>2017</year>
<volume>317</volume>
<issue>17</issue>
<fpage>1755</fpage>
<lpage>1756</lpage>
<pub-id pub-id-type="pmid">28464165</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nayfach</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>ZJ</given-names>
</name>
<name>
<surname>Seshadri</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pollard</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Kyrpides</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title>New insights from uncultivated genomes of the global human gut microbiome</article-title>
<source/>Nature
          <year>2019</year>
<volume>568</volume>
<issue>7753</issue>
<fpage>505</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="pmid">30867587</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicholson</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kinross</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Burcelin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Host-gut microbiota metabolic interactions</article-title>
<source/>Science
          <year>2012</year>
<volume>336</volume>
<issue>6086</issue>
<fpage>1262</fpage>
<lpage>1267</lpage>
<pub-id pub-id-type="pmid">22674330</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>NIH Human Microbiome Portfolio Analysis Team</collab>
</person-group>
<article-title>A review of 10 years of human microbiome research activities at the US National Institutes of Health, Fiscal Years 2007–2016</article-title>
<source/>Microbiome
          <year>2019</year>
<volume>7</volume>
<issue>1</issue>
<fpage>31</fpage>
<pub-id pub-id-type="pmid">30808411</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nissen</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Conflicts of interest and professional medical associations: progress and remaining challenges</article-title>
<source/>JAMA
          <year>2017</year>
<volume>317</volume>
<issue>17</issue>
<fpage>1737</fpage>
<lpage>1738</lpage>
<pub-id pub-id-type="pmid">28464156</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Doherty</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Virani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wilcox</surname>
<given-names>ES</given-names>
</name>
</person-group>
<article-title>The human microbiome and public health: social and ethical considerations</article-title>
<source/>Am J Public Health
          <year>2016</year>
<volume>106</volume>
<issue>3</issue>
<fpage>414</fpage>
<lpage>420</lpage>
<pub-id pub-id-type="pmid">26794165</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Hara</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The gut flora as a forgotten organ</article-title>
<source/>EMBO Rep
          <year>2006</year>
<volume>7</volume>
<issue>7</issue>
<fpage>688</fpage>
<lpage>693</lpage>
<pub-id pub-id-type="pmid">16819463</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pararajasingam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Uwagwu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Lactobacillus: the not so friendly bacteria</article-title>
<source/>BMJ Case Rep
          <year>2017</year>
<volume>2017</volume>
<fpage>bcr-2016-218423</fpage>
<pub-id pub-id-type="pmid">28903972</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pennisi</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Survey of archaea in the body reveals other microbial guests</article-title>
<source/>Science
          <year>2017</year>
<volume>358</volume>
<issue>6366</issue>
<fpage>983</fpage>
<pub-id pub-id-type="pmid">29170214</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piovani</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Danese</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Peyrin-Biroulet</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nikolopoulos</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Lytras</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bonovas</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses</article-title>
<source/>Gastroenterology
          <year>2019</year>
<volume>157</volume>
<issue>3</issue>
<fpage>647</fpage>
<lpage>659.e4</lpage>
<pub-id pub-id-type="pmid">31014995</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poussin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sierro</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Boué</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Battey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Scotti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Belcastro</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Peitsch</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>NV</given-names>
</name>
<name>
<surname>Hoeng</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Interrogating the microbiome: experimental and computational considerations in support of study reproducibility</article-title>
<source/>Drug Discov Today
          <year>2018</year>
<volume>23</volume>
<issue>9</issue>
<fpage>1644</fpage>
<lpage>1657</lpage>
<pub-id pub-id-type="pmid">29890228</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proctor</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Priorities for the next 10 years of human microbiome research</article-title>
<source/>Nature
          <year>2019</year>
<volume>569</volume>
<issue>7758</issue>
<fpage>623</fpage>
<lpage>625</lpage>
<pub-id pub-id-type="pmid">31142863</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A metagenome-wide association study of gut microbiota in type 2 diabetes</article-title>
<source/>Nature
          <year>2012</year>
<volume>490</volume>
<issue>7418</issue>
<fpage>55</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">23023125</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quince</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Loman</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Segata</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Shotgun metagenomics, from sampling to analysis</article-title>
<source/>Nat Biotechnol
          <year>2017</year>
<volume>35</volume>
<issue>9</issue>
<fpage>833</fpage>
<lpage>844</lpage>
<pub-id pub-id-type="pmid">28898207</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rastelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cani</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Knauf</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The gut microbiome influences host endocrine functions</article-title>
<source/>Endocr Rev
          <year>2019</year>
<volume>40</volume>
<issue>5</issue>
<fpage>1271</fpage>
<lpage>1284</lpage>
<pub-id pub-id-type="pmid">31081896</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehfeld</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>The new biology of gastrointestinal hormones</article-title>
<source/>Physiol Rev
          <year>1998</year>
<volume>78</volume>
<issue>4</issue>
<fpage>1087</fpage>
<lpage>1108</lpage>
<pub-id pub-id-type="pmid">9790570</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reynolds</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Early life factors that affect allergy development</article-title>
<source/>Nat Rev Immunol
          <year>2017</year>
<volume>17</volume>
<issue>8</issue>
<fpage>518</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="pmid">28504257</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhodes</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Ethical issues in microbiome research and medicine</article-title>
<source/>BMC Med
          <year>2016</year>
<volume>14</volume>
<issue>1</issue>
<fpage>156</fpage>
<pub-id pub-id-type="pmid">27729053</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richard</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2019</year>
<volume>16</volume>
<issue>6</issue>
<fpage>331</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="pmid">30824884</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ridaura</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Faith</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Rey</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Kau</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>NW</given-names>
</name>
<name>
<surname>Lombard</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Henrissat</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bain</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota from twins discordant for obesity modulate metabolism in mice</article-title>
<source/>Science.
          <year>2013</year>
<volume>341</volume>
<issue>6150</issue>
<fpage>1241214</fpage>
<pub-id pub-id-type="pmid">24009397</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rooks</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Garrett</surname>
<given-names>WS</given-names>
</name>
</person-group>
<article-title>Gut microbiota, metabolites and host immunity</article-title>
<source/>Nat Rev Immunol
          <year>2016</year>
<volume>16</volume>
<issue>6</issue>
<fpage>341</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="pmid">27231050</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosshart</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Herz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vassallo</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wall</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Badger</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>McCulloch</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Anastasakis</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Sarshad</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Leonardi</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Laboratory mice born to wild mice have natural microbiota and model human immune responses</article-title>
<source/>Science
          <year>2019</year>
<volume>365</volume>
<issue>6452</issue>
<fpage>eaaw4361</fpage>
<pub-id pub-id-type="pmid">31371577</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schiattarella</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Sannino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Toscano</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Giugliano</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gargiulo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Franzone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Trimarco</surname>
<given-names>B</given-names>
</name>
<name>
<surname>EspositoG</surname>
<given-names>Perrino C</given-names>
</name>
</person-group>
<article-title>Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis</article-title>
<source/>Eur Heart J
          <year>2017</year>
<volume>38</volume>
<issue>39</issue>
<fpage>2948</fpage>
<lpage>2956</lpage>
<pub-id pub-id-type="pmid">29020409</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schloss</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>Identifying and overcoming threats to reproducibility, replicability, robustness, and generalizability in microbiome research</article-title>
<source/>mBio
          <year>2018</year>
<volume>9</volume>
<issue>3</issue>
<fpage>e00525-18</fpage>
<pub-id pub-id-type="pmid">29871915</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname>
<given-names>TSB</given-names>
</name>
<name>
<surname>Raes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The human gut microbiome: from association to modulation</article-title>
<source/>Cell
          <year>2018</year>
<volume>172</volume>
<issue>6</issue>
<fpage>1198</fpage>
<lpage>1215</lpage>
<pub-id pub-id-type="pmid">29522742</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schroeder</surname>
<given-names>BO</given-names>
</name>
<name>
<surname>Bäckhed</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Signals from the gut microbiota to distant organs in physiology and disease</article-title>
<source/>Nat Med
          <year>2016</year>
<volume>22</volume>
<issue>10</issue>
<fpage>1079</fpage>
<lpage>1089</lpage>
<pub-id pub-id-type="pmid">27711063</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Merrifield</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Cunningham</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jobin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alverdy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>O’Keefe</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Gaskins</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Teare</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis</article-title>
<source/>Gut
          <year>2019</year>
<volume>68</volume>
<issue>9</issue>
<fpage>1624</fpage>
<lpage>1632</lpage>
<pub-id pub-id-type="pmid">31092590</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekirov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Antunes</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Gut microbiota in health and disease</article-title>
<source/>Physiol Rev
          <year>2010</year>
<volume>90</volume>
<issue>3</issue>
<fpage>859</fpage>
<lpage>904</lpage>
<pub-id pub-id-type="pmid">20664075</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Servick</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Of mice and microbes</article-title>
<source/>Science
          <year>2016</year>
<volume>353</volume>
<issue>6301</issue>
<fpage>741</fpage>
<lpage>743</lpage>
<pub-id pub-id-type="pmid">27540148</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shamarina</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stoyantcheva</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Bibby</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Elhaik</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Communicating the promise, risks, and ethics of large-scale, open space microbiome and metagenome research</article-title>
<source/>Microbiome
          <year>2017</year>
<volume>5</volume>
<issue>1</issue>
<fpage>132</fpage>
<pub-id pub-id-type="pmid">28978331</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shanahan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Language, numeracy and logic in microbiome science</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2019</year>
<volume>16</volume>
<issue>7</issue>
<fpage>387</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="pmid">31168062</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sampson</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>The central nervous system and the gut microbiome</article-title>
<source/>Cell
          <year>2016</year>
<volume>167</volume>
<issue>4</issue>
<fpage>915</fpage>
<lpage>932</lpage>
<pub-id pub-id-type="pmid">27814521</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Balasubramanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Church</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schloss</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Waterston</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>DNA sequencing at 40: past, present and future</article-title>
<source/>Nature
          <year>2017</year>
<volume>550</volume>
<issue>7676</issue>
<fpage>345</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="pmid">29019985</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shkoporov</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Bacteriophages of the human gut: the “known unknown” of the microbiome</article-title>
<source/>Cell Host Microbe
          <year>2019</year>
<volume>25</volume>
<issue>2</issue>
<fpage>195</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="pmid">30763534</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mitsuhashi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ballou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rangan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sommers</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Iturrino-Moreda</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Friedlander</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lembo</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Demographic and dietary associations of chronic diarrhea in a representative sample of adults in the United States</article-title>
<source/>Am J Gastroenterol
          <year>2018</year>
<volume>113</volume>
<issue>4</issue>
<fpage>593</fpage>
<lpage>600</lpage>
<pub-id pub-id-type="pmid">29610515</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Yeoh</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Chassaing</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Aguilera Olvera</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lapek</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W-B</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer</article-title>
<source/>Cell
          <year>2018</year>
<volume>175</volume>
<issue>3</issue>
<fpage>679</fpage>
<lpage>694.e22</lpage>
<pub-id pub-id-type="pmid">30340040</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skelly</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kearney</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Honda</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Mining the microbiota for microbial and metabolite-based immunotherapies</article-title>
<source/>Nat Rev Immunol
          <year>2019</year>
<volume>19</volume>
<issue>5</issue>
<fpage>305</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="pmid">30858494</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sox</surname>
<given-names>HC</given-names>
</name>
</person-group>
<article-title>Conflict of interest in practice guidelines panels</article-title>
<source/>JAMA
          <year>2017</year>
<volume>317</volume>
<issue>17</issue>
<fpage>1739</fpage>
<lpage>1740</lpage>
<pub-id pub-id-type="pmid">28464160</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stead</surname>
<given-names>WW</given-names>
</name>
</person-group>
<article-title>The complex and multifaceted aspects of conflicts of interest</article-title>
<source/>JAMA
          <year>2017</year>
<volume>317</volume>
<issue>17</issue>
<fpage>1765</fpage>
<lpage>1767</lpage>
<pub-id pub-id-type="pmid">28464123</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zmora</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zilberman-Schapira</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mor</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Dori-Bachash</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bashiardes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zur</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Regev-Lehavi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ben-Zeev Brik</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Federici</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT</article-title>
<source/>Cell
          <year>2018</year>
<volume>174</volume>
<issue>6</issue>
<fpage>1406</fpage>
<lpage>1423.e16</lpage>
<pub-id pub-id-type="pmid">30193113</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>The</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Dietary supplement regulation: FDA’s bitter pill</article-title>
<source/>Lancet Lond Engl
          <year>2019</year>
<volume>393</volume>
<issue>10173</issue>
<fpage>718</fpage>
</element-citation>
</ref>
<ref id="CR103">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thornton</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Conflict of interest and legal issues for investigators and authors</article-title>
<source/>JAMA
          <year>2017</year>
<volume>317</volume>
<issue>17</issue>
<fpage>1761</fpage>
<lpage>1762</lpage>
<pub-id pub-id-type="pmid">28464169</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zmora</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Adolph</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Elinav</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>The intestinal microbiota fuelling metabolic inflammation</article-title>
<source/>Nat Rev Immunol
          <year>2020</year>
<volume>20</volume>
<issue>1</issue>
<fpage>40</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">31388093</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tordesillas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Berin</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Sampson</surname>
<given-names>HA</given-names>
</name>
</person-group>
<article-title>Immunology of food allergy</article-title>
<source/>Immunity
          <year>2017</year>
<volume>47</volume>
<issue>1</issue>
<fpage>32</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">28723552</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Mahowald</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Magrini</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Mardis</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>
<source/>Nature
          <year>2006</year>
<volume>444</volume>
<issue>7122</issue>
<fpage>1027</fpage>
<lpage>1031</lpage>
<pub-id pub-id-type="pmid">17183312</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Untangle food industry influences on health</collab>
</person-group>
<source/>Nat Med
          <year>2019</year>
<volume>25</volume>
<issue>11</issue>
<fpage>1629</fpage>
<pub-id pub-id-type="pmid">31700173</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uzbay</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Germ-free animal experiments in the gut microbiota studies</article-title>
<source/>Curr Opin Pharmacol
          <year>2019</year>
<volume>49</volume>
<fpage>6</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">31051390</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaughn</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Rank</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Khoruts</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Fecal microbiota transplantation: current status in treatment of gi and liver disease</article-title>
<source/>Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc
          <year>2019</year>
<volume>17</volume>
<issue>2</issue>
<fpage>353</fpage>
<lpage>361</lpage>
</element-citation>
</ref>
<ref id="CR110">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verbeke</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Janssens</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wynendaele</surname>
<given-names>E</given-names>
</name>
<name>
<surname>De Spiegeleer</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Faecal microbiota transplantation: a regulatory hurdle?</article-title>
<source/>BMC Gastroenterol
          <year>2017</year>
<volume>17</volume>
<issue>1</issue>
<fpage>128</fpage>
<pub-id pub-id-type="pmid">29179687</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vitiello</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Harnessing the microbiome for pancreatic cancer immunotherapy</article-title>
<source/>Trends Cancer
          <year>2019</year>
<volume>5</volume>
<issue>11</issue>
<fpage>670</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="pmid">31735286</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiner</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>da Cunha</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Quintana</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Oral tolerance</article-title>
<source/>Immunol Rev
          <year>2011</year>
<volume>241</volume>
<issue>1</issue>
<fpage>241</fpage>
<lpage>259</lpage>
<pub-id pub-id-type="pmid">21488901</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Gut microbiota in colorectal cancer: mechanisms of action and clinical applications</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2019</year>
<volume>16</volume>
<issue>11</issue>
<fpage>690</fpage>
<lpage>704</lpage>
<pub-id pub-id-type="pmid">31554963</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yelin</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Flett</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Merakou</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mehrotra</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Stam</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Snesrud</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hinkle</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lesho</surname>
<given-names>E</given-names>
</name>
<name>
<surname>McGann</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McAdam</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients</article-title>
<source/>Nat Med
          <year>2019</year>
<volume>25</volume>
<issue>11</issue>
<fpage>1728</fpage>
<lpage>1732</lpage>
<pub-id pub-id-type="pmid">31700189</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoo</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>The enteric network: interactions between the immune and nervous systems of the gut</article-title>
<source/>Immunity
          <year>2017</year>
<volume>46</volume>
<issue>6</issue>
<fpage>910</fpage>
<lpage>926</lpage>
<pub-id pub-id-type="pmid">28636959</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>L-X</given-names>
</name>
<name>
<surname>Schwabe</surname>
<given-names>RF</given-names>
</name>
</person-group>
<article-title>The gut microbiome and liver cancer: mechanisms and clinical translation</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2017</year>
<volume>14</volume>
<issue>9</issue>
<fpage>527</fpage>
<lpage>539</lpage>
<pub-id pub-id-type="pmid">28676707</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae</article-title>
<source/>Cell Metab
          <year>2019</year>
<volume>30</volume>
<issue>6</issue>
<fpage>1172</fpage>
<pub-id pub-id-type="pmid">31801057</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeevi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Korem</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zmora</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Israeli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rothschild</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Weinberger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ben-Yacov</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lador</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Avnit-Sagi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lotan-Pompan</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Personalized nutrition by prediction of glycemic responses</article-title>
<source/>Cell
          <year>2015</year>
<volume>163</volume>
<issue>5</issue>
<fpage>1079</fpage>
<lpage>1094</lpage>
<pub-id pub-id-type="pmid">26590418</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeilstra</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Younes</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Brummer</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Kleerebezem</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Perspective: fundamental limitations of the randomized controlled trial method in nutritional research: the example of probiotics</article-title>
<source/>Adv Nutr Bethesda Md
          <year>2018</year>
<volume>9</volume>
<issue>5</issue>
<fpage>561</fpage>
<lpage>571</lpage>
</element-citation>
</ref>
<ref id="CR120">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Butcher</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stintzi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Figeys</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Advancing functional and translational microbiome research using meta-omics approaches</article-title>
<source/>Microbiome
          <year>2019</year>
<volume>7</volume>
<issue>1</issue>
<fpage>154</fpage>
<pub-id pub-id-type="pmid">31810497</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes</article-title>
<source/>Science
          <year>2018</year>
<volume>359</volume>
<issue>6380</issue>
<fpage>1151</fpage>
<lpage>1156</lpage>
<pub-id pub-id-type="pmid">29590046</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmermann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zimmermann-Kogadeeva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wegmann</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Separating host and microbiome contributions to drug pharmacokinetics and toxicity</article-title>
<source/>Science
          <year>2019</year>
<volume>363</volume>
<issue>6427</issue>
<fpage>eaat9931</fpage>
<pub-id pub-id-type="pmid">30733391</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zimmermann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zimmermann-Kogadeeva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wegmann</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Mapping human microbiome drug metabolism by gut bacteria and their genes</article-title>
<source/>Nature
          <year>2019</year>
<volume>570</volume>
<issue>7762</issue>
<fpage>462</fpage>
<lpage>467</lpage>
<pub-id pub-id-type="pmid">31158845</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zmora</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zeevi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Korem</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Elinav</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Taking it personally: personalized utilization of the human microbiome in health and disease</article-title>
<source/>Cell Host Microbe
          <year>2016</year>
<volume>19</volume>
<issue>1</issue>
<fpage>12</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">26764593</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuger</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>What do patients think about physicians’ conflicts of interest?: watching transparency evolve</article-title>
<source/>JAMA
          <year>2017</year>
<volume>317</volume>
<issue>17</issue>
<fpage>1747</fpage>
<lpage>1748</lpage>
<pub-id pub-id-type="pmid">28464162</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>